GRI Bio GRI
NASDAQ GRI
$1.55 +0.09 (+6.16%)
As of: Oct 21, 2026 · 10:21 AM EDT

GRI Bio (GRI) Total Debt (2020 - 2022)

Updated

GRI Bio (GRI) reported Total Debt of $602,000 for Q4 2022.

Analysis

GRI Bio (GRI) Total Debt (2020 - 2022) Analysis & Trends

  • By year, Total Debt came in at $61,000 in FY2020.
  • The Q4 2022 figure ranks as the lowest quarterly Total Debt since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,132.34 Bn 1,100.93 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 615.91 Bn 534.44 Bn 17.26 Bn 49.04 Bn
3 AbbVie 505.47 Bn 478.59 Bn 12.70 Bn 70.82 Bn
4 Merck 368.25 Bn 322.63 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 298.18 Bn 262.17 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 32.35 Bn
7 Amgen 236.22 Bn 191.62 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 190.68 Bn 164.87 Bn 6.22 Bn 26.25 Bn
9 Pfizer 170.14 Bn 116.79 Bn 10.94 Bn 63.19 Bn
10 GRI Bio 2.80 Mn -31.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 602,000.00
Dec 31, 2020 61,000.00
API Access

GRI Bio Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=GRI&period=max&api_key=YOUR_API_KEY